What are the precautions for talquetamab-tgvs?

Oral toxicity and weight loss may occur, Monitor for oral toxicity and weight loss, Withhold or permanently discontinue based on severity. Infection may occur, can result in serious, life-threatening, or fatal infection, Monitor for signs and symptoms of infection, Treat appropriately, Depending on severity, withhold or consider permanent discontinuation of treatment. Cytopenia may occur, monitor complete blood count. Skin toxicity may occur, Monitor skin toxicity, including rash progression, for early intervention and appropriate treatment, Withhold as recommended based on severity. Hepatotoxicity may occur, monitor liver enzymes and bilirubin at baseline and during treatment as clinically indicated, based on severity, suspend or consider permanent discontinuation. Embryo-Fetal toxicity may occur, May cause fetal harm, Inform women of potential risks to the fetus with reproductive potential, and use effective contraceptive measures. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.